Pivotal Research Upgrades salesforce.com (CRM) to Buy
Pivotal Research upgraded salesforce.com (NYSE: CRM) from Hold to Buy with a price target of $82.00 (from $79.00). Analyst Brian ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
